Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Mantle Cell Lymphoma · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.
This description comes directly from the study's public registry record.
Study Contact · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| City of Hope Cancer Center | Duarte, California, United States | Completed |
| University of California San Diego Medical Center | La Jolla, California, United States | Completed |
| University of California Los Angeles | Los Angeles, California, United States | Completed |
| St. Joseph Hospital Center for Cancer Prevention and Treatment | Orange, California, United States | Recruiting |
| Stanford University Medical Center | Stanford, California, United States | Completed |
| Stanford University | Stanford, California, United States | Completed |
| Norwalk Medical Group | Norwalk, Connecticut, United States | Completed |
| Northwest Georgia Oncology Centers PC | Marietta, Georgia, United States | Completed |
| Northwestern University Hospital | Chicago, Illinois, United States | Completed |
| Indiana University | Goshen, Indiana, United States | Completed |
| Kansas University Medical Center | Westwood, Kansas, United States | Completed |
| Louisville Oncology Suburban - Norton Cancer Institute | Louisville, Kentucky, United States | Completed |
+ 163 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01804686